Certified by Founder Lodge
BlackRock
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $120,000,000
137 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
BlackRock is a global asset manager and technology provider. Our purpose is to help more and more people experience financial well-being. We help millions of people invest to build savings th
| Company | Date | Round | Raised |
|---|---|---|---|
Underdog Fantasy |
July, 27 ,2022 | Series B | $35,000,000 |
Mirvie |
May, 17 ,2022 | Series B | $60,000,000 |
Aiven |
May, 11 ,2022 | Series D | $210,000,000 |
FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
Versa Networks |
October, 27 ,2022 | Unknown | $120,000,000 |
Flexe |
July, 07 ,2022 | Series D | $119,000,000 |
GreyOrange |
May, 17 ,2022 | Unknown | $110,000,000 |
FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
Underdog Fantasy |
July, 27 ,2022 | Series B | $35,000,000 |
Prosimo.io |
June, 29 ,2022 | Series B | $30,000,000 |
Aiven |
May, 11 ,2022 | Series D | $210,000,000 |
Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
Flexe |
July, 07 ,2022 | Series D | $119,000,000 |
SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
Mirvie |
May, 17 ,2022 | Series B | $60,000,000 |
10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
Prosimo.io |
June, 29 ,2022 | Series B | $30,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
GreyOrange |
May, 17 ,2022 | Unknown | $110,000,000 |
SumUp |
June, 23 ,2022 | Unknown | $624,000,000 |
FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
Mirvie |
May, 17 ,2022 | Series B | $60,000,000 |
ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
Aiven |
May, 11 ,2022 | Series D | $210,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
GreyOrange |
May, 17 ,2022 | Unknown | $110,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
Aiven |
May, 11 ,2022 | Series D | $210,000,000 |
Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
Groq |
August, 06 ,2024 | Series D | $640,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
FreeWire Technologies |
April, 27 ,2022 | Series D | $125,000,000 |
Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
Acorns |
March, 09 ,2022 | Series F | $300,000,000 |
Groq |
August, 06 ,2024 | Series D | $640,000,000 |
Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
Voltron Data |
February, 18 ,2022 | Series A | $110,000,000 |
FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
Bolt (US) |
January, 14 ,2022 | Series E | $355,000,000 |
ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
Groq |
August, 06 ,2024 | Series D | $640,000,000 |
ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
FLYR |
August, 09 ,2024 | Unknown | $295,000,000 |
ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
Groq |
August, 06 ,2024 | Series D | $640,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
Groq |
August, 06 ,2024 | Series D | $640,000,000 |
10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
FLYR |
August, 09 ,2024 | Unknown | $295,000,000 |
Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
Genesis Therapeutics |
August, 22 ,2023 | Series B | $200,000,000 |
FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
Groq |
August, 06 ,2024 | Series D | $640,000,000 |
ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
Nephron Pharmaceuticals |
September, 18 ,2023 | Unknown | $350,000,000 |
Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
10x Banking |
January, 18 ,2024 | Unknown | $44,411,000 |
Groq |
August, 06 ,2024 | Series D | $640,000,000 |
Antora Energy |
February, 23 ,2024 | Series B | $150,000,000 |
FLYR |
August, 09 ,2024 | Unknown | $295,000,000 |
Securitize |
May, 02 ,2024 | Unknown | $47,000,000 |
Caresyntax |
August, 16 ,2024 | Series C | $180,000,000 |
FintechOS |
May, 31 ,2024 | Series B | $60,000,000 |
Tuio |
September, 26 ,2024 | Unknown | $16,700,000 |
ITM Isotope Technologies Munich SE |
June, 07 ,2024 | Unknown | $204,810,020 |
Tetrix |
September, 27 ,2024 | Seed | $5,000,000 |
Astranis Space Technologies |
July, 30 ,2024 | Series D | $200,000,000 |
Double(US) |
December, 20 ,2024 | Seed | $3,900,000 |
Groq |
August, 06 ,2024 | Series D | $640,000,000 |
FLYR |
August, 09 ,2024 | Unknown | $295,000,000 |
Caresyntax |
August, 16 ,2024 | Series C | $180,000,000 |
Tuio |
September, 26 ,2024 | Unknown | $16,700,000 |
Tetrix |
September, 27 ,2024 | Seed | $5,000,000 |
Double(US) |
December, 20 ,2024 | Seed | $3,900,000 |
Underdog Fantasy
Mirvie
Aiven
FreeWire Technologies
Voltron Data
Abcuro, Inc
Nephron Pharmaceuticals
Versa Networks
Flexe
GreyOrange
Acorns
Bolt (US)
Genesis Therapeutics
10x Banking
Prosimo.io
ADARx Pharmaceuticals Inc.
Antora Energy
SumUp
Securitize
FintechOS
ITM Isotope Technologies Munich SE
Astranis Space Technologies
Groq
FLYR
Caresyntax
Tuio
Tetrix
Double(US)
Founderpath
Truework
Finix
Farther
TeamApt Inc.
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)